Latest News

The FDA designates Stoboclo and Osenvelt as interchangeable biosimilars for denosumab, enhancing treatment options for osteoporosis and cancer-related conditions.

Low RSV vaccination rates among older adults in the US highlight missed opportunities for reducing hospitalizations and healthcare costs.

Long-term benzodiazepine use has been linked to lasting cognitive impairments, underscoring the vital role pharmacists play in supporting safe deprescribing strategies.

The 20-valent pneumococcal conjugate vaccine (PCV20) demonstrated higher vaccine effectiveness against invasive pneumococcal disease or all-cause pneumonia in cohorts of older adults.

New strategies target dormant tumor cells in breast cancer, offering hope for preventing recurrence and transforming patient management.

Pharmacy students in Pakistan confront antibiotic misuse, highlighting urgent need for stewardship to combat antimicrobial resistance and protect public health.

FDA designates Conexxence and Bomyntra as interchangeable denosumab biosimilars, enhancing access and affordability for patients needing critical therapies.

Pharmacists play a vital role in vaccine education and administration.

FDA accelerated approval speeds access but faces challenges with trial completion, costs, and end point validation.

As cellular and bispecific immunotherapies move into earlier treatment lines, pharmacists are interpreting new guidelines, managing toxicities, and shaping patient care strategies.

Environmental factors significantly influence the rising rates of type 2 diabetes in children.

The agency announced that human clinical trials will no longer be required in lieu of a comparative analytical assessment to determine biosimilar equivalency with its reference product.

Liposomal vitamin C enhances bioavailability, offering superior absorption and antioxidant benefits compared with traditional forms, promising better health outcomes.

Heavy workloads, lack of recognition, and stressful environments fuel emotional exhaustion, turnover, and patient safety concerns.

COVID-19 mRNA vaccines enhance immune checkpoint inhibitor effectiveness in cancer therapy, significantly improving survival rates for patients with advanced tumors.

Data from multiple KEYNOTE clinical trials support the sustained survival benefits of pembrolizumab in non–small cell lung cancer (NSCLC).

Missteps in prescribing and counseling can escalate into catastrophic harm and significant financial liability.

Recent research reveals rising cancer rates among younger and older adults, linking obesity to increased incidence.

Pharmacist Care Day showcased UPMC Health Plan’s commitment to whole-person care through free health services, pharmacist-led outreach, and strong community collaborations in Pittsburgh.

Christina Barrington, PharmD, champions pharmacists' vital role in enhancing health care access and quality, advocating for their recognition as essential providers.

In Danish athletes, long-term anabolic androgenic steroid use was associated with progressively worsened cardiovascular outcomes.